GlassScriptPhysician profile
Cecilia House
NPI 1891108171
$5,404.19
in general payments reported to CMS, 2019-2025
43 companies · $1,469 in 2025
The $1,469 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $107 · 2021: $144 · 2022: $415 · 2023: $1,426 · 2024: $1,471 · 2025: $1,469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,366.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $661.99 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $492.78 | 2021-2024 | |
| Novo Nordisk INC | $445.95 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $344.23 | 2019-2025 | Evenity, Repatha, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $310.88 | 2023-2025 | |
| Lilly USA, LLC | $294.85 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Sanofi-Aventis U.S. LLC | $269.53 | 2023-2025 | |
| Pfizer INC. | $223.62 | 2019-2025 | |
| Exact Sciences Corporation | $215.69 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Radius Health, INC. | $209.06 | 2022-2025 | |
| Idorsia Pharmaceuticals US INC | $170.89 | 2022-2024 | Quviviq |
| Astellas Pharma US INC | $169.61 | 2023-2025 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $135.25 | 2019-2025 | Gardasil 9, Verquvo, Belsomra |
| Janssen Pharmaceuticals, INC | $127.85 | 2020-2025 | Spravato, Xarelto |
| Dexcom, INC. | $114.18 | 2023-2025 | Dexcom G6 Transmitter |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cecilia House listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.